scholarly journals Induced Pluripotent Stem Cells Regulate Triggering Receptor Expressed on Myeloid Cell-1 Expression and the p38 Mitogen-Activated Protein Kinase Pathway in Endotoxin-Induced Acute Lung Injury

Stem Cells ◽  
2019 ◽  
Vol 37 (5) ◽  
pp. 631-639 ◽  
Author(s):  
Vincent Yi-Fong Su ◽  
Kuang-Yao Yang ◽  
Shih-Hwa Chiou ◽  
Nien-Jung Chen ◽  
Min-Hsiang Mo ◽  
...  
Dose-Response ◽  
2020 ◽  
Vol 18 (4) ◽  
pp. 155932582096934
Author(s):  
Yijun Li ◽  
Shun Wang ◽  
Jinbo Liu ◽  
Xingyu Li ◽  
Meng Lu ◽  
...  

Pulmonary endothelial cell injury is a hallmark of acute lung injury. High-mobility group box 1 (HMGB1) can modulate the inflammatory response via endothelial cell activation and release of inflammatory molecules. Thus, we tested whether induced pluripotent stem cells (iPSCs) can alleviate ischemia/reperfusion (I/R) induced lung injury, and, if so, whether HMGB1 mediates the effect in a male C57BL/6 mouse model. Intravenously injected iPSCs into mice 2 h after I/R showed a significant attenuation of lung injury (assessed by lung mechanics, edema, and histology) 24 h after reperfusion (compared with controls), along with decreases in HMGB1, phosphorylated nuclear factor-κB, inflammatory cytokines [interleukin (IL)1β, IL6 and tumor necrosis factor-α], and the activation of endothelial cells. Furthermore, these effects of iPSCs can be mimicked by blocking HMGB1 with an inhibitor in vivo and in vitro. We conclude that iPSCs can be a potential therapy for I/R-induced lung injury. These cells may exert therapeutic effects through blocking HMGB1 and inflammatory cytokines.


2003 ◽  
Vol 163 (6) ◽  
pp. 2555-2563 ◽  
Author(s):  
Leo E. Otterbein ◽  
Sherrie L. Otterbein ◽  
Emeka Ifedigbo ◽  
Fang Liu ◽  
Danielle E. Morse ◽  
...  

2008 ◽  
Vol 104 (2) ◽  
pp. 405-411 ◽  
Author(s):  
Maureen Mongan ◽  
Zongqing Tan ◽  
Liang Chen ◽  
Zhimin Peng ◽  
Maggie Dietsch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document